0001104659-24-068673.txt : 20240605 0001104659-24-068673.hdr.sgml : 20240605 20240605160738 ACCESSION NUMBER: 0001104659-24-068673 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240603 FILED AS OF DATE: 20240605 DATE AS OF CHANGE: 20240605 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Edris Badreddin CENTRAL INDEX KEY: 0001786966 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 241022048 MAIL ADDRESS: STREET 1: C/O SPRINGWORKS THERAPEUTICS, INC. STREET 2: 100 WASHINGTON BLVD. CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm2416457-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-06-03 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001786966 Edris Badreddin C/O SPRINGWORKS THERAPEUTICS, INC. 100 WASHINGTON BLVD. STAMFORD CT 06902 0 1 0 0 Chief Operating Officer 1 Common Stock 2024-06-03 4 S 0 11772 39.4015 D 257828 D Common Stock 2024-06-03 4 S 0 4192 40.6219 D 253636 D Common Stock 2024-06-03 4 S 0 3651 41.3767 D 249985 D Common Stock 2024-06-03 4 S 0 385 42.0366 D 249600 D The sales reported on this Form 4 were effected pursuant to a trading plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended, adopted on February 29, 2024. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.98 to $39.96. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.98 to $40.95. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.98 to $41.955. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.99 to $42.065. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. /s/ Francis I. Perier, Jr. as Attorney-in Fact 2024-06-05